Non-classical modes of signaling by 5HT2C receptors

被引：0
|
作者：
Christopoulos, A. [1 ]
机构：
[1] Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2006年 / 101卷
关键词：
MAP kinase; RNA editing; receptor theory; stimulus-trafficking;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [1] Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors
    Christina T. Egan
    Katharine Herrick-Davis
    Keith Miller
    Richard A. Glennon
    M. Teitler
    Psychopharmacology, 1998, 136 : 409 - 414
  • [2] Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors
    Egan, CT
    Herrick-Davis, K
    Miller, K
    Glennon, RA
    Teitler, M
    PSYCHOPHARMACOLOGY, 1998, 136 (04) : 409 - 414
  • [3] INTERACTION OF CRFR1 AND 5HT2C RECEPTORS IN EXPERIMENTAL EPILEPSY
    Narla, Chakravarthi
    Poulter, Michael O.
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2013, 33 (03) : 198 - 198
  • [4] The effect of agomelatine on 5HT2C receptors in humans: a clinically relevant mechanism?
    Norman, Trevor R.
    PSYCHOPHARMACOLOGY, 2012, 221 (01) : 177 - 178
  • [5] The effect of agomelatine on 5HT2C receptors in humans: a clinically relevant mechanism?
    Trevor R. Norman
    Psychopharmacology, 2012, 221 : 177 - 178
  • [6] Modulation of dopamine transmission by 5HT2c and 5HT3 receptors:: A role in the antidepressant response
    Dremencov, E
    Weizmann, Y
    Kinor, N
    Gispan-Herman, I
    Yadid, G
    CURRENT DRUG TARGETS, 2006, 7 (02) : 165 - 175
  • [7] The synthesis of a 5HT2c receptor agonist
    Hobson, Lindsay A.
    Nugent, William A.
    Anderson, Stephen R.
    Deshmukh, Subodh S.
    Haley, James J., III
    Liu, Pingli
    Magnus, Nicholas A.
    Sheeran, Patrick
    Sherbine, James P.
    Stone, Benjan R. P.
    Zhu, Jiang
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2007, 11 (06) : 985 - 995
  • [8] m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5HT2C receptors but not 5-HT2A or 5-HT2B receptors
    Gleason, SD
    Lucaites, VL
    Shannon, HE
    Nelson, DL
    Leander, JD
    BEHAVIOURAL PHARMACOLOGY, 2001, 12 (08): : 613 - 620
  • [9] Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors
    Stahl, Stephen M.
    CNS SPECTRUMS, 2016, 21 (04) : 271 - 275
  • [10] Alcohol dependence and serotonin receptor 5HT2c
    Yoshimoto, Kanji
    Ueda, Shuichi
    Kobayasi, Masaki
    Ishikawa, Noboru
    Sakabe, Masaaki
    Hara, Junpei
    Funaki, Hironao
    Watanabe, Yoshihisa
    Tanaka, Masaki
    Ikegaya, Hiroshi
    NEUROSCIENCE RESEARCH, 2009, 65 : S256 - S256
12345